Cargando…

Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain

Detalles Bibliográficos
Autores principales:	Costello, Benedict T., Roberts, Timothy J., Howden, Erin J., Bigaran, Ashley, Foulkes, Steven J., Beaudry, Rhys I., Janssens, Kristel, Haykowsky, Mark J., Antill, Yoland, Nightingale, Sophie, Loi, Sherene, La Gerche, Andre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352105/ https://www.ncbi.nlm.nih.gov/pubmed/34396194 http://dx.doi.org/10.1016/j.jaccao.2019.09.002

Ejemplares similares

Determinants of exercise intolerance in breast cancer patients prior to anthracycline chemotherapy
por: Beaudry, Rhys I., et al.
Publicado: (2019)

Exercise as a diagnostic and therapeutic tool for preventing cardiovascular morbidity in breast cancer patients– the BReast cancer EXercise InTervention (BREXIT) trial protocol
por: Foulkes, Stephen J., et al.
Publicado: (2020)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017)

Exercise cardiovascular magnetic resonance reveals reduced cardiac reserve in pediatric cancer survivors with impaired cardiopulmonary fitness
por: Foulkes, Stephen, et al.
Publicado: (2020)

Cellular Mechanisms Mediating Exercise-Induced Protection against Cardiotoxic Anthracycline Cancer Therapy
por: Dozic, Sanela, et al.
Publicado: (2023)

Cardiac mechanisms for low aerobic power in anthracycline treated, older, long-term breast cancer survivors
por: Beaudry, Rhys I., et al.
Publicado: (2022)

Novel Therapeutics for Anthracycline Induced Cardiotoxicity
por: Vuong, Jacqueline T., et al.
Publicado: (2022)

The role of iron in anthracycline cardiotoxicity
por: Gammella, Elena, et al.
Publicado: (2014)

Updates in Anthracycline-Mediated Cardiotoxicity
por: Nebigil, Canan G., et al.
Publicado: (2018)

Metabolic Aspects of Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Genetics of Anthracycline-Associated Cardiotoxicity
por: Al-Otaibi, Talal Khalid, et al.
Publicado: (2022)

Anthracycline-induced cardiotoxicity and senescence
por: Booth, Laura K., et al.
Publicado: (2022)

Cardiac and skeletal muscle predictors of impaired cardiorespiratory fitness post-anthracycline chemotherapy for breast cancer
por: Kirkham, Amy A., et al.
Publicado: (2021)

Evaluation of biomarkers for cardiotoxicity of anthracyclin-based chemotherapy
por: Broeyer, F. J. F., et al.
Publicado: (2008)

Coronary microcirculation damage in anthracycline cardiotoxicity
por: Galán-Arriola, Carlos, et al.
Publicado: (2021)

Diffuse myocardial fibrosis by T(1)-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling
por: Tham, Edythe B, et al.
Publicado: (2013)

Anthracycline Cardiotoxicity: Prevalence, Pathogenesis and Treatment
por: Volkova, Maria, et al.
Publicado: (2011)

Cardiotoxicity of anthracycline therapy: current perspectives
por: Valcovici, Mihaela, et al.
Publicado: (2016)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
por: Chung, Woo-Baek, et al.
Publicado: (2016)

What is considered cardiotoxicity of anthracyclines in animal studies
por: Georgiadis, Nikolaos, et al.
Publicado: (2020)

What is considered cardiotoxicity of anthracyclines in animal studies
por: Georgiadis, Nikolaos, et al.
Publicado: (2020)

Anthracycline-Induced Cardiotoxicity: Remembering the Forgotten Ventricle
por: Liu, Jennifer E.
Publicado: (2020)

The Interplay Between Autophagy and Senescence in Anthracycline Cardiotoxicity
por: Russo, Michele, et al.
Publicado: (2021)

Understanding Anthracycline Cardiotoxicity From Mitochondrial Aspect
por: Huang, Junqi, et al.
Publicado: (2022)

The Quest for an Early Marker of Anthracycline-Induced Cardiotoxicity
por: Ibanez, Borja, et al.
Publicado: (2022)

Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
por: Briasoulis, Alexandros, et al.
Publicado: (2022)

Epigenetic Changes Associated With Anthracycline‐Induced Cardiotoxicity
por: Tantawy, Marwa, et al.
Publicado: (2020)

Cardiac MRI assessment of anthracycline-induced cardiotoxicity
por: Mabudian, Leila, et al.
Publicado: (2022)

Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
por: Sobiborowicz-Sadowska, Aleksandra M., et al.
Publicado: (2023)

Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!
por: El-Rayes, Malak, et al.
Publicado: (2023)

Anthracycline-induced cardiotoxicity: targeting high-density lipoproteins to limit the damage?
por: Abrahams, Carmelita, et al.
Publicado: (2022)

Novel Cardiac Computed Tomography Methods for the Assessment of Anthracycline Induced Cardiotoxicity
por: Feher, Attila, et al.
Publicado: (2022)

Intracellular magnesium concentrations and acute anthracycline-induced cardiotoxicity.
por: Sartori, S., et al.
Publicado: (1991)

Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
por: Choi, Hyoung Soo, et al.
Publicado: (2010)

Current Views on Anthracycline Cardiotoxicity in Childhood Cancer Survivors
por: Sadurska, Elżbieta
Publicado: (2015)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
por: Hu, Hui-Min, et al.
Publicado: (2018)

Statins in anthracycline-induced cardiotoxicity: Rac and Rho, and the heartbreakers
por: Henninger, Christian, et al.
Publicado: (2017)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
por: Murabito, Alessandra, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_18td98s52v7op7njh1275oelmc